Inventor · disambiguated record
Qiaolin Deng
Also filed as: DENG QIAOLIN
19 granted patents·12 pending applications·101 citations·filing 2005–2025
92Inventor score
Files withMERCK SHARP & DOHME14MERCK SHARP & DOHME LLC8ALI AMJAD2ONCOPIA THERAPEUTICS INC D/B/A/ SK LIFE SCIENCE LABS2ACTON III JOHN J1
Top patents by PatentIndex Score
31 records- 0195US7652049B2CETP inhibitorsMERCK & CO INC·Filed 2005·Granted Jan 26, 2010·54 cites·54 claims
- 0290US7737295B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Jun 15, 2010·15 cites·16 claims
- 0388US11312719B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME·Filed 2019·Granted Apr 26, 2022·4 cites·25 claims
- 0484US11492385B2Long-acting co-agonists of the glucagon and GLP-1 receptorsMERCK SHARP & DOHME·Filed 2020·Granted Nov 8, 2022·1 cites·33 claims
- 0584US10793615B2Long-acting co-agonists of the glucagon and GLP-1 receptorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 6, 2020·4 cites·17 claims
- 0683US10472347B2Aminopyrazine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2015·Granted Nov 12, 2019·5 cites·19 claims
- 0782US8735435B2CETP inhibitorsALI AMJAD·Filed 2009·Granted May 27, 2014·5 cites·9 claims
- 0881US12263171B27-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·2 cites·20 claims
- 0981US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 1078US11149036B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorACTON III JOHN J·Filed 2018·Granted Oct 19, 2021·3 cites·18 claims
- 1176US10413593B2Co-agonists of the glucagon and GLP-1 receptorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 17, 2019·2 cites·30 claims
- 1273US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 1372US2025382300A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1471US12060357B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2022·Granted Aug 13, 2024·0 cites·28 claims
- 1569US2025387397A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1668US8193365B2CETP inhibitorsALI AMJAD·Filed 2010·Granted Jun 5, 2012·1 cites·12 claims
- 1765US2025114345A1Compounds and compositions as cbp/p300 degraders and uses thereofONCOPIA THERAPEUTICS INC D/B/A/ SK LIFE SCIENCE LABS·Filed 2024·Application pending·0 cites
- 1863US2025214991A1Bicyclic heteroaryl-containing compounds as ikzf2 degradersONCOPIA THERAPEUTICS INC D/B/A/ SK LIFE SCIENCE LABS·Filed 2023·Application pending·0 cites
- 1961US12414952B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 16, 2025·0 cites·10 claims
- 2060US12466831B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 11, 2025·0 cites·14 claims
- 2160US2014221383A1Cetp inhibitorsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 2256US2023105982A1Insulin-incretin conjugatesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2354US2023270825A1Stapled olefin co-agonists of the glucagon and glp-1 receptorsMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 2454US2023063794A1Stapled triazole co-agonists of the glucagon and glp-1 receptorsMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 2551US9745295B2Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 29, 2017·0 cites·10 claims
- 2651US2016075724A1CETP InhibitorsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 2751US2023285514A1Stapled lactam co-agonists of the glucagon and glp-1 receptorsBIANCHI ELISABETTA·Filed 2020·Application pending·0 cites
- 2844US11339156B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted May 24, 2022·0 cites·11 claims
- 2943US11566057B2Long-acting co-agonists of the glucagon and GLP-1 receptorsMERCK SHARP & DOHME·Filed 2018·Granted Jan 31, 2023·0 cites·24 claims
- 3041US2007299101A1Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of TreatmentCOLLETTI STEVEN L·Filed 2005·Application pending·0 cites
- 3138US2019175744A1Insulin-incretin conjugatesPALANI ANANDAN·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →